Cargando…

The Role of the LY294002 - A Non-Selective Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) Pathway- in Cell Survival and Proliferation in Cell Line SCC-25

The activation of PI3K further activates subsequent regulatory pathways, which are activated via AKT phosphorylation. AKT is closely related to the Bcl-2 family, a protein known to be involved in cell survival. AKT also has a relationship with inflammatory and glycolytic mediators. The present work...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duarte, Andressa, Giórgia Gobbi, Giórgia Gobbi, Soave, Danilo Figueiredo, Oliveira Costa, João Paulo, Silva, Alfredo Ribeiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063005/ https://www.ncbi.nlm.nih.gov/pubmed/31759362 http://dx.doi.org/10.31557/APJCP.2019.20.11.3377

Ejemplares similares

Phosphatidylinositol 3-kinase inhibitor(LY294002) induces apoptosis of human nasopharyngeal carcinoma in vitro and in vivo
por: Jiang, Hanguo, et al.
Publicado: (2010)

Modulating effect of the PI3-kinase inhibitor LY294002 on cisplatin in human pancreatic cancer cells
por: Fujiwara, Masao, et al.
Publicado: (2008)

Synergistic Lethality of Mifepristone and LY294002 in Ovarian Cancer Cells
por: Wempe, Stacy L., et al.
Publicado: (2013)

Encapsulation of PI3K Inhibitor LY294002 within Polymer Nanoparticles Using Ion Pairing Flash Nanoprecipitation
por: Fergusson, Austin D., et al.
Publicado: (2023)

Inhibition of the PI3K/Akt pathway by Ly294002 does not prevent establishment of persistent Junín virus infection in Vero cells
por: Linero, Florencia N., et al.
Publicado: (2014)

LY294002 induces differentiation and inhibits invasion of glioblastoma cells by targeting GSK-3beta and MMP
por: Tian, Qi, et al.
Publicado: (2012)

Tamoxifen and the PI3K Inhibitor: LY294002 Synergistically Induce Apoptosis and Cell Cycle Arrest in Breast Cancer MCF-7 Cells
por: Abdallah, Mohamed E., et al.
Publicado: (2020)

LY 294002 inhibits adenosine receptor activation by a mechanism independent of effects on PI-3 kinase or casein kinase II
por: Searl, T. J., et al.
Publicado: (2005)

LY-294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF-1α pathway
por: Xu, Ruyue, et al.
Publicado: (2021)

Effect of Oxaliplatin, Olaparib and LY294002 in Combination on Triple-Negative Breast Cancer Cells
por: Andreidesz, Kitti, et al.
Publicado: (2021)

Versatile inhibitory effects of the flavonoid-derived PI3K/Akt inhibitor, LY294002, on ATP-binding cassette transporters that characterize stem cells
por: Imai, Yasuo, et al.
Publicado: (2012)

LY294002 Inhibits Intermediate Conductance Calcium-Activated Potassium (KCa3.1) Current in Human Glioblastoma Cells
por: Caglioti, Concetta, et al.
Publicado: (2022)

LY294002 Is a Promising Inhibitor to Overcome Sorafenib Resistance in FLT3-ITD Mutant AML Cells by Interfering With PI3K/Akt Signaling Pathway
por: Huang, Amin, et al.
Publicado: (2021)

LY294002 inhibits the Warburg effect in gastric cancer cells by downregulating pyruvate kinase M2
por: Lu, Jian, et al.
Publicado: (2018)

LY294002 and sorafenib as inhibitors of intracellular survival pathways in the elimination of human glioma cells by programmed cell death
por: A, Zając, et al.
Publicado: (2021)

Combined low-dose LiCl and LY294002 for the treatment of osteoporosis in ovariectomized rats
por: Bai, Jianhai, et al.
Publicado: (2019)

LY294002 alleviates bone cancer pain by reducing mitochondrial dysfunction and the inflammatory response
por: Zhao, Jiajia, et al.
Publicado: (2023)

SN50 enhances the effects of LY294002 on cell death induction in gastric cancer cell line SGC7901
por: Zhao, Kui, et al.
Publicado: (2013)

Synergistic inhibition of colon carcinoma cell growth by Hedgehog-Gli1 inhibitor arsenic trioxide and phosphoinositide 3-kinase inhibitor LY294002
por: Cai, Xinyi, et al.
Publicado: (2015)

Reversion of glucocorticoid-induced senescence and collagen synthesis decrease by LY294002 is mediated through p38 in skin
por: Le, Quoc-Vu, et al.
Publicado: (2022)

Autophagy Inhibitor (LY294002) and 5-fluorouracil (5-FU) Combination-Based Nanoliposome for Enhanced Efficacy Against Esophageal Squamous Cell Carcinoma
por: Feng, Ye, et al.
Publicado: (2018)

CD44/CD24 immunophenotypes on clinicopathologic features of salivary glands malignant neoplasms
por: Soave, Danilo Figueiredo, et al.
Publicado: (2013)

LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells
por: Shin, Jung-Young, et al.
Publicado: (2010)

The glycosyl phosphatidylinositol anchor is critical for Ly-6A/E- mediated T cell activation
Publicado: (1991)

The E3 ubiquitin ligase RNF135 regulates the tumorigenesis activity of tongue cancer SCC25 cells
por: Jin, Jian, et al.
Publicado: (2016)

Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
por: Akinleye, Akintunde, et al.
Publicado: (2013)

Acacia catechu Ethanolic Seed Extract Triggers Apoptosis of SCC-25 Cells
por: Lakshmi, Thangavelu, et al.
Publicado: (2017)

Maternally expressed 3 inhibits the biological activity of oral squamous cell carcinoma SCC25 and CAL27 cell lines
por: Wang, Wenjing, et al.
Publicado: (2021)

Phosphatidylinositol 3-Kinase (PI3K) δ blockade increases genomic instability in B cells
por: Compagno, Mara, et al.
Publicado: (2017)

Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer
por: Knowles, Margaret A., et al.
Publicado: (2009)

Cytotoxic Effect of the Genus Sinularia Extracts on Human SCC25 and HaCaT Cells
por: Wang, Guey-Horng, et al.
Publicado: (2009)

Proposal to the SCC: $\pi$-backward scattering on nuclei by the Omicron-Collaboration
por: Allardyce, Brian W, et al.
Publicado: (1977)

Prucalopride Inhibits Proliferation of Ovarian Cancer Cells via Phosphatidylinositol 3-Kinase (PI3K) Signaling Pathway
por: Liu, Xiaolin, et al.
Publicado: (2018)

PI3P-dependent regulation of cell size and autophagy by phosphatidylinositol 5-phosphate 4-kinase
por: Ghosh, Avishek, et al.
Publicado: (2023)

Inhibition of phosphatidylinositol 3‐kinase α (PI3Kα) prevents heterotopic ossification
por: Valer, José Antonio, et al.
Publicado: (2019)

Characterization and targeting of phosphatidylinositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in renal cell cancer
por: Elfiky, Aymen A, et al.
Publicado: (2011)

Phosphatidylinositol 3-kinase-δ (PI3K-δ) is a potential therapeutic target in adult T-cell leukemia-lymphoma
por: Katsuya, Hiroo, et al.
Publicado: (2018)

PI3K (Phosphatidylinositol 3-Kinase) Activation and Endothelial Cell Proliferation in Patients with Hemorrhagic Hereditary Telangiectasia Type 1
por: Iriarte, Adriana, et al.
Publicado: (2019)

The Novel Phosphatidylinositol-3-Kinase (PI3K) Inhibitor Alpelisib Effectively Inhibits Growth of PTEN-Haploinsufficient Lipoma Cells
por: Kirstein, Anna S., et al.
Publicado: (2019)

miR-183 Modulates Cell Apoptosis and Proliferation in Tongue Squamous Cell Carcinoma SCC25 Cell Line
por: Yan, Dayong, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_v7q02ctqd426svl99nu85vu6lu